Xbiotech Inc
(XBIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,416 | 31,768 | 38,977 | 45,949 | 54,632 |
| TOTAL | $29,749 | $33,332 | $40,289 | $47,301 | $57,085 |
| Non-Current Assets | |||||
| PPE Net | 29,111 | 29,640 | 30,382 | 30,540 | 30,531 |
| TOTAL | $29,111 | $29,640 | $30,382 | $30,540 | $30,531 |
| Total Assets | $58,860 | $62,972 | $70,671 | $77,841 | $87,616 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,160 | 1,730 | 2,225 | 3,385 | 2,697 |
| Accrued Expenses | 1,274 | 1,062 | 1,277 | 1,278 | 2,626 |
| TOTAL | $2,434 | $2,792 | $3,502 | $4,663 | $5,323 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 16 | 18 | 20 | 22 | 23 |
| TOTAL | $16 | $18 | $20 | $22 | $23 |
| Total Liabilities | $2,450 | $2,810 | $3,522 | $4,685 | $5,346 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,520 | 35,439 | 35,438 | 35,420 | 35,291 |
| Common Shares | 277,803 | 277,492 | 277,078 | 276,589 | 276,079 |
| Retained earnings | -220,631 | -216,562 | -209,313 | -203,107 | -193,975 |
| Other shareholders' equity | -762 | -768 | -616 | -326 | 166 |
| TOTAL | $56,410 | $60,162 | $67,149 | $73,156 | $82,270 |
| Total Liabilities And Equity | $58,860 | $62,972 | $70,671 | $77,841 | $87,616 |